Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07405554 · ClinicalTrials.gov registry record · Phase 2

Zinc Supplementation With Botulinum Toxin for Overactive Bladder

A Phase 2 study of Overactive Bladder (OAB), sponsored by Endeavor Health.

Recruiting
Registry status
Phase 2
Development phase
72
Enrollment target
1
Study location

NCT07405554 is a Phase 2 study of Overactive Bladder (OAB) that is actively recruiting participants, run by Endeavor Health. The registered enrollment target is 72 participants, below the 282-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07405554, a Phase 2 study of Overactive Bladder (OAB), is actively recruiting participants, sponsored by Endeavor Health.

RECRUITING
Registry status
Phase 2
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This randomized, double-blind, placebo-controlled trial evaluates whether oral zinc plus phytase supplementation modifies clinical response to intradetrusor botulinum toxin injection in patients with overactive bladder. Participants will receive either zinc plus phytase supplementation or matching placebo for five days prior to intradetrusor botulinum toxin injection. Participants will be followed for six months after treatment to assess need for repeat botulinum toxin injection, urinary symptoms, and patient-reported outcomes related to overactive bladder.

Conditions Studied

Overactive Bladder (OAB)

Interventions

  • DRUG Placebo
  • DRUG Zinc Citrate Oral Capsule

Study Locations (1)

Illinois

  • Endeavor Health - Skokie

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2026-02-26
Est. Completion 2026-12
Phase Phase 2

Sponsor

Endeavor Health

94 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07405554

The ClinicalTrials.gov registry entry for NCT07405554 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 282-participant average among 7 other Overactive Bladder (OAB) trials with a reported enrollment target (74% lower). The listed sponsor is Endeavor Health, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overactive Bladder (OAB) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07405554 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT07405554 about?

NCT07405554 is a clinical study titled "Zinc Supplementation With Botulinum Toxin for Overactive Bladder". This randomized, double-blind, placebo-controlled trial evaluates whether oral zinc plus phytase supplementation modifies clinical response to intradetrusor botulinum toxin injection in patients with overactive bladder. Participants will receive either zinc plus phytase supplementation or matching p...

What is the current status of trial NCT07405554?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2026-02-26. Estimated completion is 2026-12.

What conditions does trial NCT07405554 study?

This clinical trial studies the following conditions: Overactive Bladder (OAB).

What interventions are being tested in trial NCT07405554?

The interventions under investigation include: Placebo (DRUG), Zinc Citrate Oral Capsule (DRUG).

Who is sponsoring clinical trial NCT07405554?

This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07405554 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overactive Bladder (OAB)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overactive Bladder (OAB)

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.